Suven Life Sciences Ltd - 530239 - Shareholding for the Period Ended June 30, 2021
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here16-07-2021
16-07-2021
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated 12th July, 2021 regarding Notice of the 32nd Annual General Meeting of the Company and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the copies of the newspaper advertisements regarding Notice of the 32nd Annual General Meeting of the Company, Book Closure and E-Voting Information as appeared on 13th July, 2021 in Nava Telangana (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/agm.aspx.13-07-2021
Suven Life Sciences Ltd - 530239 - Reg. 34 (1) Annual Report
With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 32nd Annual General Meeting of the Members of the Company and the Annual Report for the Financial Year 2020-21 which is simultaneously circulated to the shareholders through electronic mode. The 32nd Annual General Meeting will be held on Friday, August 06th, 2021 at 11:30 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: http://www.suven.com/annualreports.aspx.12-07-2021
Suven Life Sciences Ltd - 530239 - Notice Of The Thirty Second (32Nd) Annual General Meeting (AGM) Of The Company To Be Held On Friday, 06Th August, 2021
With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 32nd Annual General Meeting of the Members of the Company and the Annual Report for the Financial Year 2020-21 which is simultaneously circulated to the shareholders through electronic mode. The 32nd Annual General Meeting will be held on Friday, August 06th, 2021 at 11:30 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: http://www.suven.com/annualreports.aspx. This is for your information and record.12-07-2021
Suven Life Sciences Ltd - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended June 30, 2021, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies Private Limited, Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Private Limited dated July 07, 2021 are enclosed for your reference. This is for your information and record.12-07-2021
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to above subject, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the copies of the newspaper advertisements as appeared on 08th July, 2021 in Nava Telangana (Telugu) and Business Standard (English). The above information will also be hosted on the website of the Company at: http://www.suven.com/agm.aspx. This is for your information and record.08-07-2021
Suven Life Sciences Ltd - 530239 - Closure of Trading Window
We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives covered under the said Code of the Company from 01st July, 2021 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending on 30th June, 2021, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This is for your information and record.30-06-2021
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to above subject, please find enclosed the copies of the newspaper advertisements, in connection with the subject referred above as required under Rule 6 (3) of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 read with the provisions of Companies Act, 2013 as appeared today i.e. June 18, 2021 in Business Standard and Nava Telangana (Telugu). The above information will also be hosted on the website of the Company at the following web link: http://www.suven.com/unpaiddividend.aspx This is for your information and record.18-06-2021
Suven Life Sciences to spend $40 mn on US clinical trials of two molecules targeting Alzheimer's
Though SUVN-502 failed to meet a phase two study in the US, trial data has shown that the drug shows some promising results on agitational symptoms of Alzheimer's patients. SUVN-G3031's clinical trial is expected to be completed in a year and a half.16-06-2021
SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg.24(A)-Annual Secretarial Compliance
With reference to above subject, please find enclosed herewith the Annual Secretarial Compliance Report of the Company from M/s. D. Renuka, Practicing Company Secretary, for the Financial Year ended 31st March, 2021, in terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019.10-06-2021